Vis enkel innførsel

dc.contributor.authorHannula, Raisa
dc.contributor.authorSöderholm, Jonas
dc.contributor.authorSvendsen, Therese
dc.contributor.authorSkaland, Maja
dc.contributor.authorNordbø, Svein A.
dc.contributor.authorSteinum, Harald
dc.contributor.authorDamås, Jan K.
dc.date.accessioned2022-04-08T08:02:34Z
dc.date.available2022-04-08T08:02:34Z
dc.date.created2021-11-09T09:40:53Z
dc.date.issued2021
dc.identifier.citationTherapeutic Advances in Infectious Disease. 2021, 8 1-11.en_US
dc.identifier.issn2049-9361
dc.identifier.urihttps://hdl.handle.net/11250/2990681
dc.description.abstractBackground: Hepatitis C is highly prevalent among people who use drugs (PWUD), and the hepatitis C virus (HCV) epidemic is less characterised in Norway. The aims of the study were to assess the prevalence and treatment willingness in high-risk populations by reaching out to frequently visited sites for high-risk populations. Methods: Individuals from high-risk populations were included from September 2015 to March 2017. Two dedicated study nurses frequently visited the local opioid substitution clinic, outpatient clinics, PWUD day centres, local prison, and refugee centre in Trondheim, Norway. Demographic data, risk behaviour, and clinical symptoms were obtained by study questionnaire. Subjects with anti-HCV+ rapid test were subsequently tested for HCV RNA and genotyped. Viraemic patients were offered referral for HCV treatment evaluation. Results: A total of 381 participants were included in the study: 52 immigrants, 62 prisoners, and 267 PWUD. The anti-HCV prevalence rates were 0% (n = 0) in immigrants, 40% (n = 25) in prisoners, and 61% (n = 164) in PWUD, with 24% (n = 15) of prisoners and 42% (n = 108) of PWUD being viraemic. Of those qualifying for treatment (n = 31), 30 wished to be evaluated. Conclusion: This study showed high HCV prevalence in prisoners and PWUD and that infected high-risk patients were interested in treatment evaluation.en_US
dc.language.isoengen_US
dc.publisherSAGEen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleHepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norwayen_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber1-11en_US
dc.source.volume8en_US
dc.source.journalTherapeutic Advances in Infectious Diseaseen_US
dc.identifier.doi10.1177/20499361211053929
dc.identifier.cristin1952628
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal